Kawai Satoru, Sato Megumi, Kato-Hayashi Naoko, Kishi Hisashi, Huffman Michael A, Maeno Yoshimasa, Culleton Richard, Nakazawa Shusuke
Laboratory of Tropical Medicine and Parasitology, Dokkyo Medical University, Mibu, Tochigi 321-0293, Japan.
Malar J. 2014 Sep 19;13:373. doi: 10.1186/1475-2875-13-373.
Diagnostic techniques based on PCR for the detection of Plasmodium DNA can be highly sensitive and specific. The vast majority of these techniques rely, however, on the invasive sampling of blood from infected hosts. There is, currently, considerable interest in the possibility of using body fluids other than blood as sources of parasite DNA for PCR diagnosis.
Urine and faeces were obtained from a Plasmodium knowlesi infected-Japanese macaque (Macaca fuscata) over the course of an experimentally induced infection. P. knowlesi DNA (PkDNA) extracted from urine and faeces were monitored by nested PCR targeting the P. knowlesi specific cytochrome b (cytb) gene.
Urinary PkDNA was detected on day 2, but was not amplified using DNA templates extracted from the samples on day 4, day 5 and day 6. Subsequently, urinary PkDNA was detected from day 7 until day 11, and from day 20 until day 30. PkDNA in faeces was detected from day 7 until day 11, and from day 20 until day 37. Moreover, real-time quantitative PCR showed a remarkable increase in the amount of urinary PkDNA following anti-malarial treatment. This might have been due to the release of a large amount of PkDNA from the degraded parasites as a result of the anti-malarial treatment, leading to excretion of PkDNA in the urine.
The cytb-PCR system using urine and faecal samples is of potential use in molecular epidemiological surveys of malaria. In particular, monkey faecal samples could be useful for the detection of zoonotic primate malaria in its natural hosts.
基于聚合酶链反应(PCR)检测疟原虫DNA的诊断技术可能具有高度敏感性和特异性。然而,这些技术绝大多数依赖于从受感染宿主进行侵入性血液采样。目前,人们对使用血液以外的体液作为PCR诊断的寄生虫DNA来源的可能性非常感兴趣。
在实验诱导感染过程中,从感染诺氏疟原虫的日本猕猴(食蟹猴)获取尿液和粪便。通过针对诺氏疟原虫特异性细胞色素b(cytb)基因的巢式PCR监测从尿液和粪便中提取的诺氏疟原虫DNA(PkDNA)。
在第2天检测到尿液中的PkDNA,但使用第4天、第5天和第6天从样本中提取的DNA模板未扩增出该DNA。随后,从第7天至第11天以及从第20天至第30天检测到尿液中的PkDNA。粪便中的PkDNA从第7天至第11天以及从第20天至第37天被检测到。此外,实时定量PCR显示抗疟治疗后尿液中PkDNA的量显著增加。这可能是由于抗疟治疗导致大量PkDNA从降解的寄生虫中释放出来,从而导致尿液中PkDNA的排泄。
使用尿液和粪便样本的cytb-PCR系统在疟疾分子流行病学调查中具有潜在用途。特别是,猴粪便样本可能有助于在其自然宿主中检测人畜共患的灵长类疟疾。